ARCHIVES

How Much Is Life Worth? The $440 Billion Question

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

In Brief: Gregory Curt May Return As Director Of COP; Koop Locked In as Surgeon General Until Nov.

January 20, 1989

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Knudson wins Kyoto prize; King wins genetics prize.

June 18, 2004